Web-based Genetic Research on Parkinson's Disease

23andMe logo

23andMe

Status

Completed

Conditions

Parkinson's Disease

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01351467
23andMe_PD001

Details and patient eligibility

About

The purpose of this study is to examine how genes and environment affect risk for Parkinson's disease.

Full description

23andMe has created a web-based Parkinson's research initiative to understand the genetic associations found between Parkinson's patients' DNA and their disease. To learn more, visit: https://www.23andme.com/pd/. You can participate in this research initiative without leaving home. If you are eligible to participate, we will send you an in-home 23andMe DNA kit at no cost. We will ask you short online surveys (15-20) about your Parkinson's journey, symptoms, and response to treatment. Enrollment is on-going and open to individuals who have been diagnosed with Parkinson's disease and are residents of the U.S. Participants receive access to ancestry information and uninterpreted genetic data. Participants will also receive regular updates on our research efforts and findings.

Enrollment

13,576 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

diagnosis of Parkinson's disease by a physician

Exclusion criteria

diagnoses other than Parkinson's, including:

  • progressive supranuclear palsy (PSP)
  • multiple system atrophy (MSA)
  • Shy-Drager syndrome
  • spinal cerebella ataxia (SCA)
  • atypical parkinsonism
  • parkinsonism due to medications, drug-induced parkinsonism
  • vascular parkinsonism
  • frontotemporal dementia with parkinsonism

Trial design

13,576 participants in 1 patient group

Parkinson's disease patients
Description:
People diagnosed with Parkinson's disease by a physician

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems